Clinical Trials in Illinois

Showing 17121-17140 of 19,692 trials

A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With Asthma

NCT00590720

The main objective of this study is to evaluate the safety and tolerability of multiple fixed doses of MEDI-528 in adult patients with stable asthma and exercise-induced bronchoconstriction (EIB).

Asthma

MedImmune LLC11 participantsStarted Mar 2008

San Diego, California, United States • Denver, Colorado, United States • Waterbury, Connecticut, United States +9 more locations

COMPLETEDPhase 311 miles

DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension

NCT00389779

This is a randomized, double-blind, placebo- and active-controlled study of a new experimental drug called darusentan. Darusentan is not currently approved by the United States Food and Drug Administration (FDA), which means that a doctor cannot prescribe this drug. The purpose of this study is to determine if darusentan is effective in reducing systolic and diastolic hypertension despite treatment with full doses of three or more antihypertensive drugs, including a diuretic. Subjects will be randomized to darusentan (optimized dose), an active comparator, or placebo, administered orally. The treatment period for this trial is 14 weeks.

Hypertension

Gilead Sciences849 participantsStarted Sep 2006

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +144 more locations

A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With Asthma

DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension

Find Trials by Condition in Illinois

JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events

A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA)

Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis

Cross-Over Study of Sevelamer Hydrochloride and Sevelamer Carbonate

Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone

DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension

Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With Bronchiectasis

Long-term Effects of Highly Active Anti-Retroviral Therapy on HIV-Infected Children

Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers

Truvada Versus Truvada Plus Hepatitis B Immunoglobulin (HBIg) in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant

Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients

Study Evaluating Vabicaserin in Subjects With Schizophrenia

Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy

Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS CLIA

Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy

Safety Study of GC1008 in Patients With Focal Segmental Glomerulosclerosis (FSGS) of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic FSGS

To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function